MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2026 International Congress

    Expanding the Childhood Spectrum of Dentatorubral–pallidoluysian Atrophy: Neuropsychiatric and Motor Phenotypes in Four Siblings

    M. Siegel, I. Malaty, A. Ramirez-Zamora (Gainesville, USA)

    Objective: We aim to characterize the striking clinical heterogeneity of movement, epileptic, and neuropsychiatric symptoms in a cohort of four siblings with genetically confirmed DRPLA.…
  • 2026 International Congress

    Diffusion MRI Evidence of Cerebellar Involvement in Cognitive Dysfunction in Parkinson’s Disease

    A. Vijayakumari, L. Saadatpour, D. Floden, K. Sakaie, H. Kaur, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To determine whether cerebellar axonal microstructural abnormality is associated with cognitive performance in PD. Background: Cognitive impairment in Parkinson’s disease (PD) often affects executive…
  • 2026 International Congress

    Verbal Communication After Subthalamic Nucleus Deep Brain Stimulation

    F. Rodriguez-Porcel, T. Turner, M. Sowlat, K. Richardson, G. Revuelta, D. Lench (Charelston, USA)

    Objective: To evaluate the contribution of motor speech, language, and cognition to communication changes after subthalamic nucleus deep brain stimulation (STN-DBS) in people with Parkinson’s…
  • 2026 International Congress

    Optimal and invariant hierarchical cognitive indices in the Parkinson’s Progression Markers Initiative

    D. González, W. Kent, G. Springer, A. Karstens (Chicago, USA)

    Objective: To expand cognitive indices derived from PPMI cognitive battery (PPMI-CB) by testing hierarchical models and measurement invariance across pertinent groups. Background: Parkinson’s can cause…
  • 2026 International Congress

    Fibrinogen and CFAH as putative biomarkers for Parkinson’s disease

    P. Alladi, S. Choudhury, R. Bhavani, NC. Krithika, K. Krishnakumari, H. Jyothi, A. Mahadevan, P. Pal, V. Holla, S. Hegde, N. Kamble, R. Yadav (Bengaluru, India)

    Objective: To examine the levels of putative biomarkers FIB, CFAH, gelsolin (GSN), α-syn and phosphorylated-α-syn in PD serum. To localize and quantify FIB and CFAH in…
  • 2026 International Congress

    Adult hippocampal neurogenesis and cognitive and neuropsychiatric symptoms in Parkinson’s disease: the MemHiN study

    L. Batzu, A. Podlewska, S. Farmand, F. Derbyshire-Fox, A. Woods, N. Crane, C. Pariante, S. Thuret (London, United Kingdom)

    Objective: To examine associations between serum-derived adult hippocampal neurogenesis (AHN)1 markers and cognitive and neuropsychiatric symptoms in Parkinson’s disease (PD), and to explore whether a…
  • 2026 International Congress

    The Effect of Depression on the Cognitive Phenotype in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia.

    C. Hurtado-González, J. Ayala-Rico, S. Ospina Otalvaro, P. Gutiérrez-Lenis, A. Cubides-Munévar, A. Botero-Carvajal, J. Centeno-Arispe, D. Reyes-Torres, K. Ponce-Gil, J. Cedeño-Buitrago, L. Ortega-Bolaños (Cali, Colombia)

    Objective: To investigate the impact of depression on cognitive functioning in a group of older adults without dementia. Background: Parkinson’s disease (PD) is a neurodegenerative…
  • 2026 International Congress

    Effectiveness of Acupuncture for Parkinson’s Disease with Mild Cognitive Impairment A Randomized Clinical Trial

    II. Leong, SN. Wu, JQ. Fan, LX. Zhuang (Guangzhou, China)

    Objective: To evaluate the efficacy and safety of acupuncture for PD-MCI, and improve the credibility of acupuncture research evidence through employing a sham acupuncture device…
  • 2026 International Congress

    Online Assessments Measure Motor and Cognitive Progression in People with and without Parkinson’s Disease

    E. Brown, X. Chen, P. Gonzalez Latapi, D. Weintraub, C. Marras, N. Pavese, L. Chahine, W. Poewe, R. Dobkin, K. Chou, E. Tolosa, A. Noyce, C. Stanley, T. Tropea, L. Racelo, M. Korell, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To evaluate longitudinal progression in online participant reported outcomes (PROs) among people with Parkinson’s disease (PD), prodromal PD, and healthy controls. Background: Collecting PROs…
  • 2026 International Congress

    Increased Pre-Alpha EEG Functional Connectivity Forecasts Future Cognitive Decline in Parkinson’s Disease

    A. Tetereva, G. Hall-Mcmaster, N. Slater, A. Harris, R. Shoorangiz, C. Le Heron, R. Keenan, I. Kirk, W. Meissner, T. Anderson, T. Melzer, N. Pat, J. Dalrymple-Alford (Christchurch, New Zealand)

    Objective: To evaluate whether resting-state EEG functional connectivity (rsEEG-FC) forecasts cognitive decline three years later in Parkinson’s disease (PD). Background: Cognitive performance and trajectories of…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley